Your browser doesn't support javascript.
loading
Impact of healthcare inequities on survival in Mexican patients with metastatic renal cell carcinoma.
Bourlon, Maria T; Remolina-Bonilla, Yuly A; Acosta-Medina, Aldo A; Saldivar-Oviedo, Bruno I; Perez-Silva, Antonio; Martinez-Ibarra, Nayeli; Castro-Alonso, Francisco Javier; Martín-Aguilar, Ana E; Rivera-Rivera, Samuel; Mota-Rivero, Fernando; Pérez-Pérez, Perla; Díaz-Alvarado, María G; Ruiz-Morales, José M; Campos-Gómez, Saúl; Martinez-Cannon, Bertha Alejandra; Lam, Elaine T; Sobrevilla-Moreno, Nora.
Afiliação
  • Bourlon MT; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Remolina-Bonilla YA; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Acosta-Medina AA; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Saldivar-Oviedo BI; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Perez-Silva A; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Martinez-Ibarra N; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Castro-Alonso FJ; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Martín-Aguilar AE; Department of Medical Oncology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
  • Rivera-Rivera S; Department of Medical Oncology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
  • Mota-Rivero F; Department of Medical Oncology, Centro Médico Nacional Siglo XXI, Mexico City, Mexico.
  • Pérez-Pérez P; Department of Medical Oncology, Centro Médico Nacional 20 Noviembre, Mexico City, Mexico.
  • Díaz-Alvarado MG; Department of Medical Oncology, Centro Médico Nacional 20 Noviembre, Mexico City, Mexico.
  • Ruiz-Morales JM; Comprehensive Cancer Center, Médica Sur, Mexico City, Mexico.
  • Campos-Gómez S; Statal Oncologic Center, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico.
  • Martinez-Cannon BA; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Lam ET; Department of Hematology and Medical Oncology, University of Colorado Cancer Center, Aurora, CO, United States.
  • Sobrevilla-Moreno N; Department of Medical Oncology, Instituto Nacional de Cancerología, Mexico City, Mexico.
Front Oncol ; 13: 1229016, 2023.
Article em En | MEDLINE | ID: mdl-38044992

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: México País de publicação: Suíça